sábado, 9 de abril de 2022

T cell response against SARS-CoV-2 persists after one year in patients surviving severe COVID-19 - eBioMedicine

T cell response against SARS-CoV-2 persists after one year in patients surviving severe COVID-19 - eBioMedicine

No hay comentarios:

Publicar un comentario